Jordyn Woods Criticizes Weight-Loss Drug Culture

Woods, who previously launched the size-inclusive activewear line SECNDNTURE, remains vocal about her decision to avoid the weight-loss drug trend. The 28-year-old emphasized that her weight naturally fluctuates and stated that she remains uninterested in the medications, noting, “Everyone’s skinny now. The bug hasn’t caught me yet.” Her commitment to body positivity stems from her own experiences in the modeling industry, where she learned to view her individuality as her greatest asset.

While Woods resists the trend, other public figures have adopted GLP-1 treatments to manage health and weight. Rosie O’Donnell, 64, recently shared her experience with Mounjaro on the “Bleep!” podcast. O’Donnell described the medication as a “miracle drug” that has helped her quiet the persistent “food noise” she battled for years. After struggling with weight throughout her adult life, O’Donnell credited the drug with allowing her to establish healthier habits, noting she has spent three years microdosing to avoid side effects like nausea and vomiting. The divergence between Woods’ focus on inclusivity and O’Donnell’s medical approach highlights the growing debate surrounding the impact of these drugs on celebrity culture and personal health narratives.